Levalbuterol is as effective as racemic albuterol in lowering serum potassium

Journal of Emergency Medicine

Volumn 25, Issue 1, 2003, Pages 13-16

  Pancu, Diana ^a   LaFlamme, Michelle ^b   Evans, Elizabeth ^b   Reed, James ^b  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b ST LUKE S HOSPITAL   (United States)

Author keywords

Albuterol; Hyperkalemia; Levalbuterol; Potassium

Indexed keywords

LEVALBUTEROL; PLACEBO; POTASSIUM ION; SALBUTAMOL; SODIUM CHLORIDE;

ARTICLE; CHRONOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; DRUG SCREENING; HEART PALPITATION; HUMAN; HUMAN EXPERIMENT; MEASUREMENT; NEBULIZATION; NERVOUSNESS; NORMAL HUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECORDING; SIDE EFFECT; TACHYCARDIA; TREMOR;

EID: 0037632494     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(03)00133-1     Document Type: Article

References (20)

1. Weiner I.D., Wingo C.S. Hyperkalemia a potential silent killer . J Am Soc Nephrol. 9:1998;1535-1546.
2. Allon M., Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients interactions with insulin and albuterol . Am J Kidney Dis. 28:1996;508-514.
3. Kim H.J. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron. 72:1996;476-482.
4. Greenberg A. Hyperkalemia treatment options . Semin Nephrol. 18:1998;46-57.
5. Allon M., Copkney C. Albuterol and insulin for the treatment of hyperkalemia in hemodialysis patients. Kidney Int. 38:1990;869-872.
6. Blumberg A., Weidman P., Shaw S., Gnadinger M. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med. 85:1988;507-512.
7. Allon M., Dunlay R., Copkney C. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med. 110:1989;426-429.
8. Liou H.H., Chiang S.S., Wu S.C., et al. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure comparative study . Am J Kidney Dis. 23:1994;266-271.
9. McClure R.J., Prasad V.K., Brocklebank J.T. Treatment of hyperkalemia using intravenous and nebulized salbutamol. Arch Dis Child. 70:1994;126-128.
10. Montoliu J., Almirall J., Ponz E., Campistol J.M., Revert L. Treatment of hyperkalemia in renal failure with salbutamol inhalation. J Intern Med. 228:1990;35-37.
11. Lens X.M., Montoliu J., Cases A., Campistol J.M., Revert L. Treatment of hyperkalemia in renal failure salbutamol v. insulin . Nephrol Dial Transplant. 4:1989;228-232.
12. Page C.P. Contrasting properties of albuterol stereoisomers. J Allergy Clin Immunol. 104:1999;S31-41.
13. Nelson H.S., Bensch G., Pleskow W.W., et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol. 102:1998;943-952.
14. Gawchick S.M. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma pediatric patients. J Allergy Clin Immunol. 103:1999;615-621.
15. Handley D.A. Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma. J Asthma. 37:2000;123-129.
16. Ahee P., Crowe A.V. The management of hyperkalemia in the emergency department. J Accid Emerg Med. 17:2000;188-191.
17. Alvestrand A., Wahren J., Smith D., Defonzo R.A. Insulin-mediated potassium uptake is normal in uremic and healthy subjects. Am J Physiol. 246:1984;E174-180.
18. Braden G.L., Germain M.J., Mulhern J.G., Hafer J.G., Bria W.F. Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients. Chest. 114:1998;380-387.
19. Millar E.A., Connell J.M.C., Thompson N.C. The effect of nebulized albuterol on the activity of the renin-angiotensin system in asthma. Chest. 111:1997;71-74.
20. Mandelberg A., Krupnik Z., Houri S., et al. Salbutamol metered-dose inhaler with spacer for hyperkalemia. How fast? How safe? Chest. 115:1999;617-622.